Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population

Journal of Infectious Diseases

Volumn 206, Issue 2, 2012, Pages 190-196

  Tseng, Hung Fu ^a   Chi, Margaret ^a   Smith, Ning ^a   Marcy, Stephen M ^a   Sy, Lina S ^a   Jacobsen, Steven J ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HERPES ZOSTER; HUMAN; IMMUNOCOMPETENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; UNITED STATES; VACCINATION;

AGED; CALIFORNIA; COHORT STUDIES; FEMALE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; IMMUNOCOMPETENCE; INCIDENCE; MALE; MIDDLE AGED; RECURRENCE;

EID: 84862846909     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis334     Document Type: Article

References (21)

1. Zostavax (herpes zoster vaccine) questions and answers. http://www. fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/UCM070418. Accessed 3 October 2011.
2. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008; 57:1-30; quiz CE2-4.
3. Shingles vaccination: what you need to know. http://www.cdc.gov/vaccines/ vpd-vac/shingles/vacc-need-know.htm Accessed 3 October 2011.
4. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84.
5. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 2011; 305:160-6.
6. Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 2011; 86:88-93.
7. Arvin AM, Koropchak CM, Wittek AE. Immunologic evidence of reinfection with varicella-zoster virus. J Infect Dis 1983; 148:200-5.
8. Gershon AA, Steinberg SP, Gelb L. Clinical reinfection with varicellazoster virus. J Infect Dis 1984; 149:137-42.
9. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002; 347:340-6.
10. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1995; 155:1605-9.
11. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58:9-20.
12. Cohen JL, Straus SE, Arvin AM. Varicella-zoster virus replication, pathogenesis and management. In: Knipe DM, Howley PM, eds. Fields virology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2007:2773-818.
13. Straus SE, Schmader KE, Oxman MN. Varicella and herpes zoster. In: Fitzpatrick TB, Freedberg IM, Eisen AZ, et al., eds. Fitzpatrick's dermatology in general medicine. 6th ed. New York, NY: McGraw-Hill book Company, 2003:2070-85.
14. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005; 352:2266-7.
15. Arvin AM. Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis 2008; 197(Suppl 2):S58-60.
16. Weinberg A, Zhang JH, Oxman MN, et al. Varicella-zoster virusspecific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 2009; 200:1068-77.
17. Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995; 45:S41-6.
18. Distler E, Schnurer E, Wagner E, et al. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation. Biol Blood Marrow Transplant 2008; 14:1417-24.
19. Klompas M, Kulldorff M, Vilk Y, Bialek SR, Harpaz R. Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clin Proc 2011; 86:1146-53.
20. Chien AJ, Olerud JE. Why do so many clinicians believe that recurrent zoster is common? Dermatol Online J 2007; 13:2.
21. Heskel NS, Hanifin JM. "Recurrent herpes zoster": an unproved entity? J Am Acad Dermatol 1984; 10:486-90.